Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 "EMERGE" Study
Yazar
Fu, Tommy
Zhang, Lei
Cicero, Sherri
Witzig, Thomas E.
Besisik, Sevgi
Goy, Andre
Sinha, Rajni
Williams, Michael E.
Drach, Johannes
Ramchandren, Radhakrishnan
Robertson, Michael J.
Avivi, Irit
Rowe, Jacob M.
Herbrecht, Raoul
Van Hoof, Achiel
Egyed, Miklos
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]